Regeneron hopes for full FDA approval of COVID-19 antibody cocktail

A new medicine to treat COVID-19 could be on the way as the Food and Drug Administration has started its review of 's COVID-19 antibody cocktail.
The Tarrytown-based biotech company says the FDA accepted its priority review application and they are hoping to receive full approval
The treatment currently has emergency use authorization.
Regeneron wants full approval to treat patients infected with the virus who are not in the hospital.